InterVene, Inc. recently announced that it has received 510(k) clearance from the FDA for its Recana thrombectomy catheter ...

Surmodics, Inc. announced results from a sex-specific analysis of its ongoing PROWL registry evaluating real-world use of the ...

Amplitude Vascular Systems (AVS) announced results from the first 95 patients treated in the POWER PAD II United States ...

Contego Medical announced 30-day outcomes from the PERFORMANCE III study evaluating the Neuroguard IEP system for direct transc ...

Johnson & Johnson MedTech announced 1-year results from the DISRUPT BTK II postmarket study, demonstrating sustained safety ...

BD announced full enrollment of the iliac artery patient cohort in its pivotal AGILITY investigational device exemption (IDE) ...

Merit Medical Systems, Inc. announced 24-month efficacy outcomes from the nonrandomized arteriovenous graft (AVG) cohort of the ...

The Centers for Medicare & Medicaid Services (CMS) has released the final National Coverage Determination (NCD) on renal de ...

Penumbra, Inc. announced that results of the STORM-PE randomized controlled trial (RCT) were presented at VIVA 2025, the Vascul ...

Gore & Associates announced FDA approval of a 6- to 10-mm diameter range for the Viatorr TIPS—transjugular intrahepat ...

Elucid announced the launch of its PlaqueIQ image analysis software for the quantification and classification of plaque ...

InspireMD, Inc. announced the appointment of Peter A. Soukas, MD, as Chief Medical Officer. InspireMD is the developer of the C ...